Insurance Denied Genetic Testing? Your Appeal Rights

Genetic testing has moved from research laboratories to routine clinical practice. BRCA1/2 testing identifies women at high risk for hereditary breast and ovarian cancer. Lynch syndrome testing guides colorectal cancer surveillance. Pharmacogenomic tests reveal how individual patients metabolize specific medications. Despite the growing clinical importance of these tests and explicit endorsement by major medical organizations, genetic testing remains one of the most frequently denied services by health insurers. A denial is not the end of the road — the legal and clinical arguments for appeal are often compelling.

Why Insurers Deny Genetic Testing

Insurers deny genetic testing claims using a predictable set of rationales. The most common is a medical necessity dispute: the insurer applies internal criteria narrower than current clinical guidelines from the National Comprehensive Cancer Network (NCCN), the American College of Medical Genetics and Genomics (ACMG), or the American College of Obstetricians and Gynecologists (ACOG). A second common basis is an experimental or investigational label, applied even when the test has FDA clearance and is recommended by national specialty societies. Policy exclusions create a third category: some plans exclude genetic testing unless very specific criteria are met, such as a first-degree relative with cancer diagnosed before age 50. Ordering physician criteria generate administrative denials when an insurer requires a genetic counselor or medical geneticist to order the test but the ordering provider was a primary care physician or specialist. Finally, CPT and ICD-10 code mismatches — incorrect billing codes or a mismatch between the diagnosis code and the test ordered — cause administrative denials that are typically straightforward to correct.

How to Appeal a Genetic Testing Denial

Step 1: Identify the Specific Denial Basis

Read the denial letter carefully to identify whether the denial rests on medical necessity, an experimental label, a policy exclusion, ordering physician criteria, or a billing code issue. Each requires a different legal and clinical argument. Under ACA §2719 (42 U.S.C. §300gg-19) and ERISA §1133 (29 U.S.C. §1133), you are entitled to the specific clinical criteria the insurer used.

Step 2: Obtain the Insurer's Clinical Criteria

Request in writing the complete clinical coverage criteria the insurer applied to your denial. Compare them to NCCN, ACMG, or ACOG guidelines. Insurer criteria are frequently more restrictive than published medical standards — this discrepancy is the core of many successful appeals.

Step 3: Obtain a Detailed Letter from the Ordering Physician

The ordering physician or genetic counselor should write a letter explaining the specific clinical indication for the test, your personal or family history meeting published testing criteria, the relevant ICD-10 diagnosis code, why the test result will change clinical management, and a direct rebuttal of the insurer's denial basis with guideline citations. For BRCA1/2 testing (CPT 81211–81213, 81215–81217), cite NCCN Genetic/Familial High-Risk Assessment guidelines and the USPSTF Grade B recommendation for BRCA counseling and testing in women with a family history suggesting BRCA mutations. For Lynch syndrome testing (MLH1, MSH2, MSH6, PMS2), cite NCCN and ACMG guidelines supporting universal tumor testing at colorectal cancer diagnosis.

Step 4: Invoke ACA Preventive Services Mandates for BRCA Testing

If your test involves BRCA counseling and testing and you meet USPSTF criteria, ACA §2713 (42 U.S.C. §300gg-13) requires ACA-compliant, non-grandfathered plans to cover the test with no cost-sharing. This is a clear legal argument: the insurer is legally required to cover the test at no cost to you, and denial constitutes a statutory violation. State this explicitly in your appeal.

Step 5: Assert GINA Protections

The Genetic Information Nondiscrimination Act (GINA, 29 U.S.C. §1181 note) prohibits health insurers from using genetic information to discriminate in coverage decisions. If your plan covers genetic testing for some members but denied your test based on your specific genetic information or family history, cite GINA as an additional legal basis for reversal.

Step 6: File the Internal Appeal and Request External Independent Review: Complete Guide" class="auto-link">External Review

Submit your written appeal before the deadline — typically 180 days for post-service claims. Include the physician letter, NCCN/ACMG/ACOG guideline excerpts, family history documentation, and a point-by-point rebuttal of every stated denial reason. If the internal appeal is denied, immediately request external independent review. Hereditary cancer testing denials are frequently overturned at external review when the physician's documentation clearly meets NCCN or USPSTF criteria.

What to Include in Your Genetic Testing Appeal

• Written denial letter and EOB)" class="auto-link">Explanation of Benefits (EOB) identifying the specific denial reason and policy clause cited
• Ordering physician's or genetic counselor's letter with ICD-10 diagnosis code, clinical indication, family history summary, and direct rebuttal of the insurer's denial basis
• Excerpts from NCCN, ACMG, or ACOG guidelines showing your clinical situation meets established testing criteria — for pharmacogenomic testing (CPT 81225, 81226, 81227), include relevant CPIC guideline references
• The insurer's own clinical criteria document obtained under ACA §2719 or ERISA §1133, with a side-by-side comparison showing how your case meets those criteria or how they conflict with published medical standards
• Laboratory documentation confirming FDA clearance or regulatory status of the test, and a Certificate of Prior Coverage or USPSTF Grade B recommendation if asserting ACA §2713 coverage rights

Fight Back With ClaimBack

Genetic testing denial is one of the most commonly reversed denial types when appealed with the correct clinical and regulatory arguments. With USPSTF Grade B recommendations requiring ACA-compliant plans to cover BRCA testing at no cost, and NCCN guidelines supporting hereditary cancer panel testing, the insurer's position is often legally and clinically indefensible. ClaimBack generates a professional, guideline-based appeal letter targeting your specific denial in 3 minutes. Start your free claim analysis → Free analysis · No credit card required · Takes 3 minutes

Related Reading

• How to Write an Insurance Appeal Letter
• What Is Medical Necessity?
• Internal vs External Insurance Appeal